Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anders E. Kolb"'
Autor:
Christopher E. Dandoy, Stella M. Davies, Kwang Woo Ahn, Yizeng He, Anders E. Kolb, John Levine, Stephanie Bo-Subait, Hisham Abdel-Azim, Neel Bhatt, Joseph Chewning, Shahinaz Gadalla, Nicholas Gloude, Robert Hayashi, Nahal R. Lalefar, Jason Law, Margaret MacMillan, Tracy O'Brien, Timothy Prestidge, Akshay Sharma, Peter Shaw, Lena Winestone, Mary Eapen
Publikováno v:
Haematologica, Vol 106, Iss 7 (2020)
With limited data comparing hematopoietic cell transplant outcomes between myeloablative total body irradiation (TBI) containing and non-TBI regimens in children with de novo acute myeloid leukemia, the aim of this study was to compare transplant-out
Externí odkaz:
https://doaj.org/article/5e1ad268425b42f087f5d0fcff1b7103
Autor:
Alireza Torabi, Todd A. Alonzo, Megan Othus, Robert B. Gerbing, Yi-Cheng Wang, Rhonda E. Ries, Jerald P. Radich, Frederick R. Appelbaum, Kristin O'Dwyer, Harry P. Erba, Martin S. Tallman, Mark R. Litzow, Ehab L. Atallah, Selina M. Luger, Anders E. Kolb, Omar Abdel-Wahab, Derek Stirewalt, Ross L. Levine, Elisabeth Paietta, Soheil Meshinchi
Publikováno v:
Blood. 140:745-747
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c547abf3eb933f33b45e738f4c3bb086
https://doi.org/10.1182/blood-2022-162526
https://doi.org/10.1182/blood-2022-162526
Autor:
Jenny Ruiz, Yimei Li, Yuan-Shung V. Huang, Lusha Cao, Vicky Tam, Heather M. Griffis, Lena E. Winestone, Brian T. Fisher, Todd A. Alonzo, Anders E. Kolb, Karen Glanz, Kelly D. Getz, Richard Aplenc, Alix E. Seif
Publikováno v:
Blood. 140:11029-11031
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05e989f20aa4a8f779f7a2ee80ac0f49
https://doi.org/10.1182/blood-2022-163573
https://doi.org/10.1182/blood-2022-163573
Autor:
Danielle C. Kirkey, Xiaoying Wu, Rhonda E. Ries, Tiffany A. Hylkema, Yanling Liu, Pandurang Kolekar, Quang Tran, Alan S. Gamis, Richard Aplenc, Anders E. Kolb, Todd A. Alonzo, Katherine Tarlock, Robert Eisenman, Soheil Meshinchi
Publikováno v:
Blood. 140:3395-3396
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77ee444e5ec054605a05417491f1552e
https://doi.org/10.1182/blood-2022-168469
https://doi.org/10.1182/blood-2022-168469
Autor:
Jason E Farrar, Jenny L. Smith, Megan Othus, Benjamin J. Huang, Yi-Cheng Wang, Rhonda E. Ries, Tiffany A. Hylkema, Era L Pogosova-Agadjanyan, Sneha Challa, Amanda R. Leonti, Timothy I. Shaw, Timothy Junius Triche, Alan S. Gamis, Richard Aplenc, Anders E. Kolb, Xiaotu Ma, Derek Stirewalt, Todd A. Alonzo, Soheil Meshinchi
Publikováno v:
Blood. 140:9173-9174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::537d9182faa23ac3c8f3e3046a36543a
https://doi.org/10.1182/blood-2022-168296
https://doi.org/10.1182/blood-2022-168296
Autor:
Anders E. Kolb, Todd A. Alonzo, Steven M. Kornblau, Richard Aplenc, Peter P. Ruvolo, Fieke W Hoff, Sophia W.M. Bruggeman, Eveline S. J. M. de Bont, Anneke D. van Dijk, Yihua Qiu, Terzah M. Horton, Robert B. Gerbing, Alan S. Gamis
Publikováno v:
Blood, 134. AMER SOC HEMATOLOGY
The proteasome degrades unneeded and damaged proteins. Tumor cells highly depend on increased protein production and their degradation suggesting that malignant cells with a high proliferation index will be more sensitive to proteasome inhibition. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f464c8a18efd61bbd5608892c0b4f8b
https://research.rug.nl/en/publications/b633c36a-c056-43aa-9f76-2dde7e698a15
https://research.rug.nl/en/publications/b633c36a-c056-43aa-9f76-2dde7e698a15
Autor:
Catherine A. Billups, Patrick Reynolds, Min H. Kang, Hernan Carol, John M. Maris, Malcolm A. Smith, Anders Kolb, Peter J. Houghton, Raushan T. Kurmasheva, Richard B. Lock, Richard Gorlick, Stephen T. Keir
Publikováno v:
Cancer Research. 75:1615-1615
The Curaxin, CBL0137, is a member of a new class of small molecules that simultaneously activate p53 and inhibit cancer-associated stress response pathways such as NFκB and Heat Shock Factor 1. CBL0137 sequesters the FACT (FAcilitates Chromatin Tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::355361b4e0b23bfdf3b90b7d7c793e2c
https://doi.org/10.1158/1538-7445.am2015-1615
https://doi.org/10.1158/1538-7445.am2015-1615
Autor:
Peter J. Houghton, Brendan Murphy, Igor Dvorchik, Richard Gorlick, Anders Kolb, Patrick Reynolds, Han Yin, Jianrong Wu, Raushan T. Kurmasheva, John M. Maris, Malcolm A. Smith, Catherine A. Billups, Stephen T. Keir, Min H. Kang
Publikováno v:
Cancer Research. 75:1617-1617
Traditional approaches to evaluating antitumor agents using human tumor xenograft models have usually used 8-10 mice in control and treatment groups against a limited panel of tumor models. However, with increasing evidence of molecular/genetic subse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcb3645d99100619be00e72d9854df01
https://doi.org/10.1158/1538-7445.am2015-1617
https://doi.org/10.1158/1538-7445.am2015-1617
Autor:
Gorlick Richard, Smith A. Malcolm, Houghton Peter, Jianrong Wu, Anders Kolb, Kurmasheva T. Raushan
Publikováno v:
Cancer Research. 74:A81-A81
Introduction: The Halichondrin B analog, eribulin (Halaven), is FDA approved for third line treatment of breast cancer after anthracycline/taxane therapy. Previously, the PPTP identified eribulin as having significant broad-spectrum activity against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca96418e1a59a436ae1b58c3033a2cb5
https://doi.org/10.1158/1538-7445.pedcan-a81
https://doi.org/10.1158/1538-7445.pedcan-a81